PIKFYVE and neoplasm: Previous work has shown that inhibition of PIKfyve decreased the cellular levels of PtdIns(3,5)P2 and PtdIns5P28 and disrupted autophagy flux and lysosome function, leading to increased immune activity and tumour suppression in multiple cancer models29–32.